Sara J. Buhrlage
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 13
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 21
- Protein Degradation and Inhibitors 14
- Histone Deacetylase Inhibitors Research 6
- Oncology top 5%
- Peptidase Inhibition and Analysis 9
- Hematology top 5%
- Acute Myeloid Leukemia Research 7
- Chronic Myeloid Leukemia Treatments 5
-
- Click Chemistry and Applications 7
- Co-authors
- Nathanael S. GrayQingsong LiuTinghu ZhangZheng ZhaoYogesh SabnisLyn H. JonesXiaoxi LiuNathan J. Schauer
- Cited by
- GeneticsMolecular BiologyOncology
- Journals
- Nature (2 papers)Proceedings of the National Academy of Sciences (3 papers)Journal of the American Chemical Society (2 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Sara J. Buhrlage
60 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Genetics 437
- Molecular Biology 1.9k
- Oncology 717
- Hematology 254
- Pathology and Forensic Medicine 369
Countries citing papers authored by Sara J. Buhrlage
This map shows the geographic impact of Sara J. Buhrlage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara J. Buhrlage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara J. Buhrlage more than expected).
Fields of papers citing papers by Sara J. Buhrlage
This network shows the impact of papers produced by Sara J. Buhrlage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara J. Buhrlage. The network helps show where Sara J. Buhrlage may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sara J. Buhrlage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 9 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 26 | |
| 7 | 2021 | 19 | |
| 8 | 2021 | 21 | |
| 9 | 2021 | 4 | |
| 10 | 2020 | 19 | |
| 11 | 2020 | 26 | |
| 12 | 2020 | 1 | |
| 13 | 2018 | 46 | |
| 14 | 2017 | 137 | |
| 15 | 2016 | 115 | |
| 16 | 2015 | 35 | |
| 17 | 2014 | 259 | |
| 18 | 2013 | 138 | |
| 19 | Developing Irreversible Inhibitors of the Protein Kinase Cysteinomebreakdown → | 2013 | 513 |
| 20 | 2012 | 36 |
About Sara J. Buhrlage
Sara J. Buhrlage is a scholar working on Genetics, Hematology and Oncology, having authored 66 papers that have together received 2.9k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (21 papers), Protein Degradation and Inhibitors (14 papers), Chronic Lymphocytic Leukemia Research (13 papers), Peptidase Inhibition and Analysis (9 papers), Acute Myeloid Leukemia Research (7 papers), Click Chemistry and Applications (7 papers), Histone Deacetylase Inhibitors Research (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). The work is most often cited by research in Genetics (437 citations), Molecular Biology (1.9k citations) and Oncology (717 citations). Sara J. Buhrlage has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Nathanael S. Gray, Qingsong Liu, Tinghu Zhang, Zheng Zhao, Yogesh Sabnis, Lyn H. Jones, Xiaoxi Liu, Nathan J. Schauer, Robert S. Magin and Laura M. Doherty. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.